ASPREVA PHARMACEUTICALS EARNS $3.2M US Q3 PROFIT COMPARED WITH LOSS YEAR AGO

Aspreva Pharmaceuticals Corp. earned $3.2 million US in its latest quarter compared with a loss a year ago, the company said Wednesday. The Victoria-based drug developer, which records its results in U.S. dollars, earned nine cents per share for the three months ended Sept. 30, compared with a loss of $5.8 million or 45 cents per share a year ago. Aspreva earned $16.8 million in royalty revenue in the quarter compared with none in the third quarter last year.

Canada.com (http://www.canada.com/health/story.html?id=fe8c33ca-ccf1-461c-92d7-3d89992dff59%20)